| 5-chloro-N-(4-((S)-5-((5-chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)-N-(2-(2-oxo-2-((((S)-2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)amino)ethoxy)ethyl)thiophene-2-carboxamide |
利伐沙班开环二聚体 |
1632463-24-1 |
| 2-ThiophenecarboxaMide, N-[[(5S)-2-oxo-3-[4-(3-oxo-4-Morpholinyl)phenyl]-5-oxazolidinyl]Methyl]- |
利伐沙班杂质A |
1415566-28-7 |
| DoMperidone EP IMpurity F |
多潘立酮EP杂质F |
1391053-55-6 |
| DoMperidone EP IMpurity B |
多潘立酮EP杂质B |
1346598-11-5 |
| Dabigatran Etexilate iMpurity H |
达比加群酯杂质H |
1702936-92-2 |
| DoMperidoneiMpurityE |
多潘立酮杂质E |
1346602-50-3 |
| 9-Keto Risperidone |
帕潘立酮9-酮杂质 |
1189516-65-1 |
| 1-(1H-benzo[d]imidazol-2-yl)-3-methyl-4-oxo-1,4-dihydropyridine-2-carboxylic acid |
雷贝拉唑USP RC A |
1163685-30-0 |
| Bortezomib Impurity 9 |
硼替佐米杂质 9 |
1194235-41-0 |
| OlMesartan DiMer Ester IMpurity |
奥美沙坦酯杂质IV |
1040250-19-8 |
| Sarpogrelate iMpurity |
沙格雷酯杂质 |
1140968-46-2 |
| ((R)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxaMido)propanaMido)butyl)boronic acid |
硼替佐米杂质-异构体 |
1132709-15-9 |
| Quetiapine N-Oxide |
奎硫平N -氧化物 |
1076199-40-0 |
| Parecoxib SodiuM iMpurity D |
帕瑞昔布钠杂质D |
198470-92-7 |
| (1R,2R)-ethyl2-(3,4-difluorophenyl)cyclopropane carboxylate |
(1R,2R)-2-(3,4-二氟苯基)环丙烷羧酸乙酯 |
1006376-61-9 |
| (R)-9-[2-(DIETHYLPHOSPHONOMETHOXY)PROPYL] ADENINE |
(R)-9-[2-(二乙基膦酰甲氧基)丙基]腺嘌呤 |
180587-75-1 |
| 2-[(1-Benzylpiperidin-4-yl)hydroxyMethyl]-5,6-diMethoxyindan-1-one |
羟基多萘哌齐(异构体混合) |
197010-20-1 |
| 6,7,8,9-Dehydro Paliperidone Hydrochloride |
6,7,8,9-脱氢盐酸帕利哌酮 |
170359-61-2 |
| Fludarabine Phosphate iMpurity F |
磷酸氟达拉滨杂质F |
159002-28-5 |
| Paliperidone Impurity 4 |
帕利哌酮开环杂质 |
152542-03-5 |
